Alnylam Pharmaceuticals, Inc. (ALNY)
USD 224.32
(-3.7%)
USD 224.32
(-3.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.51 Billion USD | 74.75% |
| 2022 | 868.6 Million USD | 23.36% |
| 2021 | 704.14 Million USD | 69.75% |
| 2020 | 414.8 Million USD | 113.06% |
| 2019 | 194.68 Million USD | 166.31% |
| 2018 | 73.1 Million USD | -4.49% |
| 2017 | 76.54 Million USD | 62.31% |
| 2016 | 47.15 Million USD | 14.75% |
| 2015 | 41.09 Million USD | -18.72% |
| 2014 | 50.56 Million USD | 7.2% |
| 2013 | 47.16 Million USD | -29.31% |
| 2012 | 66.72 Million USD | -19.37% |
| 2011 | 82.75 Million USD | -17.28% |
| 2010 | 100.04 Million USD | -0.49% |
| 2009 | 100.53 Million USD | 4.54% |
| 2008 | 96.16 Million USD | 88.94% |
| 2007 | 50.89 Million USD | 89.0% |
| 2006 | 26.93 Million USD | 371.13% |
| 2005 | 5.71 Million USD | 33.61% |
| 2004 | 4.27 Million USD | 2330.68% |
| 2003 | 176 Thousand USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 416.22 Million USD | -29.8% |
| 2024 Q1 | 428.35 Million USD | 21.05% |
| 2024 Q2 | 591.15 Million USD | 38.0% |
| 2023 Q4 | 353.86 Million USD | -46.89% |
| 2023 Q3 | 666.22 Million USD | 185.46% |
| 2023 Q2 | 233.38 Million USD | -11.74% |
| 2023 Q1 | 264.42 Million USD | -6.82% |
| 2023 FY | 1.51 Billion USD | 74.75% |
| 2022 Q4 | 283.76 Million USD | 27.14% |
| 2022 Q1 | 177.63 Million USD | -19.58% |
| 2022 Q2 | 184.01 Million USD | 3.59% |
| 2022 FY | 868.6 Million USD | 23.36% |
| 2022 Q3 | 223.19 Million USD | 21.29% |
| 2021 Q2 | 181.79 Million USD | 24.09% |
| 2021 Q3 | 154.97 Million USD | -14.76% |
| 2021 FY | 704.14 Million USD | 69.75% |
| 2021 Q4 | 220.87 Million USD | 42.53% |
| 2021 Q1 | 146.5 Million USD | 4.25% |
| 2020 Q2 | 84.03 Million USD | -2.48% |
| 2020 Q4 | 140.53 Million USD | 35.06% |
| 2020 Q3 | 104.05 Million USD | 23.83% |
| 2020 FY | 414.8 Million USD | 113.06% |
| 2020 Q1 | 86.17 Million USD | 44.82% |
| 2019 Q4 | 59.5 Million USD | -8.24% |
| 2019 FY | 194.68 Million USD | 166.31% |
| 2019 Q2 | 40.38 Million USD | 34.86% |
| 2019 Q1 | 29.94 Million USD | 54.62% |
| 2019 Q3 | 64.84 Million USD | 60.56% |
| 2018 Q3 | 1.93 Million USD | -93.54% |
| 2018 Q4 | 19.36 Million USD | 902.48% |
| 2018 FY | 73.1 Million USD | -4.49% |
| 2018 Q1 | 21.89 Million USD | -42.26% |
| 2018 Q2 | 29.9 Million USD | 36.57% |
| 2017 FY | 76.54 Million USD | 62.31% |
| 2017 Q2 | 15.93 Million USD | -15.97% |
| 2017 Q4 | 37.92 Million USD | 121.83% |
| 2017 Q3 | 17.09 Million USD | 7.31% |
| 2017 Q1 | 18.96 Million USD | 8.63% |
| 2016 Q4 | 17.45 Million USD | 27.86% |
| 2016 Q2 | 8.7 Million USD | 18.57% |
| 2016 FY | 47.15 Million USD | 14.75% |
| 2016 Q1 | 7.34 Million USD | -2.73% |
| 2016 Q3 | 13.65 Million USD | 56.75% |
| 2015 Q2 | 8.68 Million USD | -53.15% |
| 2015 Q4 | 7.55 Million USD | 19.4% |
| 2015 Q3 | 6.32 Million USD | -27.18% |
| 2015 FY | 41.09 Million USD | -18.72% |
| 2015 Q1 | 18.53 Million USD | -22.82% |
| 2014 Q2 | 7.29 Million USD | -11.84% |
| 2014 Q3 | 10.97 Million USD | 50.4% |
| 2014 Q4 | 24.01 Million USD | 118.91% |
| 2014 FY | 50.56 Million USD | 7.2% |
| 2014 Q1 | 8.27 Million USD | -23.71% |
| 2013 Q3 | 8.99 Million USD | 3.5% |
| 2013 Q1 | 18.64 Million USD | 119.45% |
| 2013 Q2 | 8.68 Million USD | -53.4% |
| 2013 FY | 47.16 Million USD | -29.31% |
| 2013 Q4 | 10.84 Million USD | 20.64% |
| 2012 Q4 | 8.49 Million USD | -49.31% |
| 2012 Q1 | 20.58 Million USD | 0.65% |
| 2012 Q3 | 16.75 Million USD | -19.75% |
| 2012 FY | 66.72 Million USD | -19.37% |
| 2012 Q2 | 20.88 Million USD | 1.44% |
| 2011 Q4 | 20.45 Million USD | -1.62% |
| 2011 Q2 | 20.61 Million USD | -1.35% |
| 2011 Q1 | 20.89 Million USD | -1.39% |
| 2011 FY | 82.75 Million USD | -17.28% |
| 2011 Q3 | 20.79 Million USD | 0.86% |
| 2010 Q3 | 27.66 Million USD | 3.95% |
| 2010 FY | 100.04 Million USD | -0.49% |
| 2010 Q1 | 24.56 Million USD | -7.74% |
| 2010 Q2 | 26.61 Million USD | 8.36% |
| 2010 Q4 | 21.19 Million USD | -23.41% |
| 2009 FY | 100.53 Million USD | 4.54% |
| 2009 Q4 | 26.62 Million USD | 9.8% |
| 2009 Q3 | 24.24 Million USD | -1.43% |
| 2009 Q2 | 24.6 Million USD | -1.82% |
| 2009 Q1 | 25.05 Million USD | 2.68% |
| 2008 Q1 | 22.19 Million USD | 21.72% |
| 2008 Q4 | 24.4 Million USD | -5.17% |
| 2008 Q3 | 25.73 Million USD | 7.98% |
| 2008 FY | 96.16 Million USD | 88.94% |
| 2008 Q2 | 23.83 Million USD | 7.39% |
| 2007 Q2 | 9.13 Million USD | 26.55% |
| 2007 Q4 | 18.23 Million USD | 11.75% |
| 2007 FY | 50.89 Million USD | 89.0% |
| 2007 Q1 | 7.21 Million USD | 3.38% |
| 2007 Q3 | 16.31 Million USD | 78.64% |
| 2006 Q3 | 8.21 Million USD | 36.37% |
| 2006 Q4 | 6.98 Million USD | -14.98% |
| 2006 Q1 | 5.71 Million USD | 268.36% |
| 2006 FY | 26.93 Million USD | 371.13% |
| 2006 Q2 | 6.02 Million USD | 5.32% |
| 2005 Q1 | 1.64 Million USD | -37.91% |
| 2005 Q4 | 1.55 Million USD | 9.84% |
| 2005 FY | 5.71 Million USD | 33.61% |
| 2005 Q3 | 1.41 Million USD | 27.53% |
| 2005 Q2 | 1.1 Million USD | -32.56% |
| 2004 Q1 | 134 Thousand USD | 204.55% |
| 2004 Q2 | 131 Thousand USD | -2.24% |
| 2004 FY | 4.27 Million USD | 2330.68% |
| 2004 Q4 | 2.64 Million USD | 93.56% |
| 2004 Q3 | 1.36 Million USD | 943.51% |
| 2003 FY | 176 Thousand USD | 0.0% |
| 2003 Q4 | 44 Thousand USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | 44 Thousand USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1159.928% |
| Jaguar Health, Inc. | 7.72 Million USD | -19551.554% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 228697.289% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 30357820.0% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1167.514% |
| ContextLogic Inc. | 59 Million USD | -2472.688% |
| MiMedx Group, Inc. | 266.84 Million USD | -468.831% |
| MEI Pharma, Inc. | 49.32 Million USD | -2977.191% |
| AlloVir, Inc. | -398 Thousand USD | 381478.392% |
| Novavax, Inc. | 639.93 Million USD | -137.193% |
| Aptorum Group Limited | -1.11 Million USD | 136271.377% |
| Ardelyx, Inc. | 106.66 Million USD | -1323.094% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -530.522% |
| Psyence Biomedical Ltd. | -240.00 USD | 632452600.0% |
| Vaxcyte, Inc. | -75 Million USD | 2123.848% |
| Precigen, Inc. | 106 Thousand USD | -1431867.925% |
| Pharming Group N.V. | 220.1 Million USD | -589.622% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -294635.146% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -150334.688% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1282.762% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 936.725% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 293839.284% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1271.932% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 3448.894% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 7003.561% |
| Acelyrin, Inc. | -115 Thousand USD | 1320000.87% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 265929.422% |
| Senti Biosciences, Inc. | -2.68 Million USD | 56674.208% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -37369.415% |
| AbCellera Biologics Inc. | 38.02 Million USD | -3891.811% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 31735.807% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1264805.0% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -5110.91% |
| Chimerix, Inc. | 324 Thousand USD | -468383.333% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -305925.403% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1851180.488% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 4970.067% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 308613.415% |
| Elevation Oncology, Inc. | -39 Thousand USD | 3892115.385% |
| Alkermes plc | 1.37 Billion USD | -10.417% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2523.695% |
| Fortress Biotech, Inc. | 57.85 Million USD | -2523.695% |
| Agenus Inc. | 139.61 Million USD | -987.194% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -9056.578% |
| Dyadic International, Inc. | 922.95 Thousand USD | -164359.016% |
| ImmuCell Corporation | 4.39 Million USD | -34426.568% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -7107.094% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 1530.308% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 868242.276% |
| Immix Biopharma, Inc. | -5468.00 USD | 27759536.723% |
| Incyte Corporation | 3.44 Billion USD | 55.884% |
| IO Biotech, Inc. | -756 Thousand USD | 200878.571% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 3340.646% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 11463.253% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 3435163.818% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 1645.441% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 2759892.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -189162.594% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 288123.909% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -5065.161% |
| NextCure, Inc. | -3.68 Million USD | 41302.117% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -7870.834% |
| Onconetix, Inc. | -1.12 Million USD | 134764.047% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 5339.872% |
| Opthea Limited | 21.72 Thousand USD | -6988325.414% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 2647914.255% |
| PureTech Health plc | -1.6 Million USD | 94790.331% |
| Pyxis Oncology, Inc. | -2 Million USD | 75994.3% |
| Seer, Inc. | 7.02 Million USD | -21500.768% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 15101940.613% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -19184.538% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 38605.011% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -357891.981% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1358.118% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1022.124% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 1665.638% |
| ChromaDex Corporation | 50.78 Million USD | -2889.141% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 654361.207% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2056.089% |
| CRISPR Therapeutics AG | 240.95 Million USD | -529.943% |
| Precision BioSciences, Inc. | 40.47 Million USD | -3650.46% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 1646.291% |
| Innoviva, Inc. | 261.06 Million USD | -481.421% |
| Summit Therapeutics Inc. | -2.05 Million USD | 74143.22% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -34570.763% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -6945.189% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1281113.748% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1059329.175% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -249142.365% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -383.909% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -58869.93% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 2991597.832% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 21484.7% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 319961.341% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 14595157.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -1559729.824% |
| Century Therapeutics, Inc. | -10.8 Million USD | 14142.798% |
| Kura Oncology, Inc. | -849 Thousand USD | 178885.159% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2361.99% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1032675.51% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -1432.614% |
| Autolus Therapeutics plc | -4.86 Million USD | 31287.302% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -3567.632% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 903603.571% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -1502.447% |
| GRI Bio, Inc. | 10.84 Million USD | -13901.347% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -59659.621% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 17573.075% |
| IGM Biosciences, Inc. | -211.66 Million USD | 817.134% |
| INmune Bio, Inc. | 155 Thousand USD | -979181.29% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -2350.614% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 100869.772% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 234177.668% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 5185199.406% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -377483.582% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 76146.393% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 485047.604% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -1506.892% |
| Verastem, Inc. | -62 Thousand USD | 2448303.226% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -62236.181% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 581665.517% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -50044.896% |
| Histogen Inc. | 3.76 Million USD | -40172.911% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -263340.007% |
| Surrozen, Inc. | -27.23 Million USD | 5674.315% |
| Organovo Holdings, Inc. | -5.38 Million USD | 28266.376% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 126078.189% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 6018.376% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -7469.749% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 76661009.091% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -24921.104% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 2261180.574% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -880.604% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1040974.074% |
| Apollomics, Inc. | 127 Thousand USD | -1195085.827% |
| Amarin Corporation plc | 165.54 Million USD | -816.925% |
| Mesoblast Limited | -9.81 Million USD | 15564.962% |
| Turnstone Biologics Corp. | 16.5 Million USD | -9095.965% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 1473.789% |
| Synaptogenix, Inc. | -6347.00 USD | 23915114.968% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 2976347.059% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -840.654% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 13.642% |
| Better Therapeutics, Inc. | -2.72 Million USD | 55720.594% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 1453.31% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -348.971% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 13305552.314% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 24347.38% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 137093.321% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -20641.812% |
| Insmed Incorporated | 239.63 Million USD | -533.416% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -42322.75% |
| OmniAb, Inc. | 14.66 Million USD | -10248.988% |
| Alector, Inc. | -95.05 Million USD | 1696.884% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1108.306% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 3592.364% |
| Zai Lab Limited | 170.9 Million USD | -788.156% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1753.861% |
| Aura Biosciences, Inc. | -1.29 Million USD | 117311.274% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1167504.615% |
| Immunic, Inc. | -111 Thousand USD | 1367564.865% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -9474.152% |
| Veracyte, Inc. | 248.14 Million USD | -511.686% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 121.718% |
| FibroGen, Inc. | 128.9 Million USD | -1077.532% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 269128823.404% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 13110.208% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 55.338% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -390102.057% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -327.158% |
| TG Therapeutics, Inc. | 219.1 Million USD | -592.757% |
| Galecto, Inc. | -830 Thousand USD | 182977.831% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 109694.657% |
| Fortrea Holdings Inc. | 424 Million USD | -257.992% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 1861.563% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 267804.762% |
| XBiotech Inc. | -1.74 Million USD | 87134.748% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 137093.321% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 3366.308% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2109.54% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -1967.88% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -8933.423% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -290.162% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 3157.357% |
| Vaxxinity, Inc. | -2.23 Million USD | 68044.763% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -364.539% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 13504.338% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -6107.869% |
| NexImmune, Inc. | -1.02 Million USD | 148190.484% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -28108900.0% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 21461.659% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 86.569% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 2271466.364% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 42845.311% |
| Ainos, Inc. | -253.73 Thousand USD | 598321.753% |
| Pluri Inc. | 322 Thousand USD | -471293.168% |
| Prothena Corporation plc | -129.2 Million USD | 1274.825% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -2910.249% |
| Celularity Inc. | 6.75 Million USD | -22370.555% |
| Rallybio Corporation | -150 Thousand USD | 1012024.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 4755.092% |
| MeiraGTx Holdings plc | 287 Thousand USD | -528780.139% |
| Omeros Corporation | -69.77 Million USD | 2275.276% |
| Humacyte, Inc. | -76.55 Million USD | 2082.869% |
| Immunocore Holdings plc | 248.39 Million USD | -511.087% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 10106.5% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -2333.212% |
| Blueprint Medicines Corporation | 236.58 Million USD | -541.584% |
| CalciMedica, Inc. | -58 Thousand USD | 2617144.828% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 106543.619% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -5124.182% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 53471.519% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 5017.823% |
| Pulmatrix, Inc. | -8.22 Million USD | 18565.766% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 129833.846% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 380522.556% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 480.619% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -54587.066% |
| Cytokinetics, Incorporated | -322.59 Million USD | 570.527% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -175967.416% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 445227.859% |
| Vor Biopharma Inc. | -3.49 Million USD | 43567.526% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1289.56% |
| Evogene Ltd. | 1.39 Million USD | -108397.927% |
| ProKidney Corp. | -3.16 Million USD | 47997.949% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 3556.654% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -22036.299% |
| CorMedix Inc. | -205.56 Thousand USD | 738507.877% |
| BioLineRx Ltd. | 1.1 Million USD | -136893.321% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2029.41% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 4599754.545% |
| Atai Life Sciences N.V. | -5000.00 USD | 30357820.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1245708.449% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 1581231.25% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 109379.05% |
| Sagimet Biosciences Inc. | 2 Million USD | -75794.3% |
| MediciNova, Inc. | 979.7 Thousand USD | -154832.965% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1900.171% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1605394.273% |
| GeoVax Labs, Inc. | -20.72 Million USD | 7425.434% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -520.723% |
| Biomea Fusion, Inc. | -4.2 Million USD | 36231.54% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -74.002% |
| Mereo BioPharma Group plc | 7.42 Million USD | -20340.156% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 489740.645% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 12649150.0% |
| Absci Corporation | -41.84 Million USD | 3727.054% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 30357820.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2087.464% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 61777.611% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -610.172% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 161405.632% |
| Allakos Inc. | -6.14 Million USD | 24817.245% |
| Imunon, Inc. | -720 Thousand USD | 210916.036% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 2299.962% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -218.955% |
| BioAtla, Inc. | -103.73 Million USD | 1563.291% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 13305552.314% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 852844.944% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 725.11% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 488166.238% |
| XOMA Corporation | 3.86 Million USD | -39213.287% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 2265.779% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -10160.146% |
| aTyr Pharma, Inc. | -2.38 Million USD | 63663.065% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -12082.071% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 5234189.655% |
| Viridian Therapeutics, Inc. | -1 Million USD | 150683.929% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -11676046053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 37947250.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -138.327% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -779470.434% |
| UroGen Pharma Ltd. | 73.35 Million USD | -1969.318% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 5786.244% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -13073853.488% |
| Orgenesis Inc. | -5.72 Million USD | 26613.293% |
| Entera Bio Ltd. | -56 Thousand USD | 2710610.714% |
| GH Research PLC | -315 Thousand USD | 481968.571% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 803214.286% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 289221.143% |
| Xencor, Inc. | -85.26 Million USD | 1880.303% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 686997.731% |
| Replimune Group, Inc. | -2.65 Million USD | 57270.847% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 151701.221% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -753.493% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -779470.434% |
| Portage Biotech Inc. | -54 Thousand USD | 2811000.0% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 1605394.273% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 402722.281% |
| OncoCyte Corporation | 413 Thousand USD | -367426.877% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 33768420.356% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 683732532.432% |
| Purple Biotech Ltd. | -196 Thousand USD | 774531.633% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -16825.58% |
| scPharmaceuticals Inc. | 9.78 Million USD | -15417.134% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 14632.238% |
| HilleVax, Inc. | -2.15 Million USD | 70502.876% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 1564930.928% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 10116642.255% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 227328.443% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 6599604.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 20221971.103% |
| Savara Inc. | -44.26 Million USD | 3529.321% |
| Curis, Inc. | 9.81 Million USD | -15371.267% |
| Daré Bioscience, Inc. | 2.76 Million USD | -54706.786% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1216471.767% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 87889.821% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 665839.474% |
| BeiGene, Ltd. | 2.07 Billion USD | 26.985% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 54389.71% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 479.791% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -2577.614% |
| Erasca, Inc. | -3.73 Million USD | 40772.186% |
| bluebird bio, Inc. | -4.03 Million USD | 37764.665% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 5379240.974% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 20.295% |
| DBV Technologies S.A. | 15.72 Million USD | -9550.852% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 5379240.974% |
| Moderna, Inc. | 2.15 Billion USD | 29.564% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 165989.18% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -18859.355% |
| Molecular Templates, Inc. | 50.39 Million USD | -2911.977% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 283287.687% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1034.546% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 24495.468% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 3958.084% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 1465.89% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 42404.515% |
| MacroGenics, Inc. | 50.52 Million USD | -2904.109% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 24991.538% |
| Prime Medicine, Inc. | -147.9 Million USD | 1126.257% |
| Aditxt, Inc. | -111.66 Thousand USD | 1359482.053% |
| Adagene Inc. | 18.11 Million USD | -8280.79% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -310942.213% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -982.642% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -861.686% |
| SciSparc Ltd. | 2.19 Million USD | -69020.492% |
| Vericel Corporation | 135.57 Million USD | -1019.583% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 6059767.053% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 4899351.178% |
| Generation Bio Co. | -73.91 Million USD | 2153.667% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 347442.334% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -2679.044% |
| Invivyd, Inc. | -2.02 Million USD | 74946.45% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 604.548% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 1467535.565% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -1475.093% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -1444.325% |
| ADMA Biologics, Inc. | 88.21 Million USD | -1620.608% |
| Clene Inc. | 533 Thousand USD | -284681.614% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -6195.883% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 158708.777% |
| GeoVax Labs, Inc. | -20.72 Million USD | 7425.434% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -76252.414% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 781243.087% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -2947.658% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 21502.792% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 181665.311% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -1719.68% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2076010.625% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -2755.209% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 976.438% |
| Trevena, Inc. | 1.45 Million USD | -104222.062% |
| Surrozen, Inc. | -27.23 Million USD | 5674.315% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 430096.034% |
| Cingulate Inc. | -582.91 Thousand USD | 260494.429% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 4896506.452% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 7805.396% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 20051434.214% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 172391.26% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -122.987% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 153732.186% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 2694157.719% |
| Kronos Bio, Inc. | 1.37 Million USD | -110533.09% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 2928.394% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 519923.973% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 310942.204% |
| ImmunityBio, Inc. | -17.89 Million USD | 8584.55% |
| Korro Bio, Inc. | -3.63 Million USD | 41915.041% |
| Kineta, Inc. | 5.43 Million USD | -27838.266% |
| BioVie Inc. | -229.37 Thousand USD | 661842.895% |
| Codexis, Inc. | 57.33 Million USD | -2547.445% |
| Celularity Inc. | 6.75 Million USD | -22370.555% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -37724.221% |
| Celcuity Inc. | -142.77 Thousand USD | 1063253.84% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -3000267.662% |
| Cibus, Inc. | 1.42 Million USD | -106643.038% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 405951.872% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 6722.828% |
| IN8bio, Inc. | -2.5 Million USD | 60791.164% |
| Kodiak Sciences Inc. | -25.94 Million USD | 5949.948% |
| Annexon, Inc. | -3.26 Million USD | 46561.157% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 74360.568% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 3736.788% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -237069.688% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -94.972% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -777.619% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 79988.737% |
| Arcellx, Inc. | 108.27 Million USD | -1301.829% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 4789.32% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -1816.426% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 7276.087% |
| Moolec Science SA | -143.3 Thousand USD | 1059299.609% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 3686.857% |
| Geron Corporation | -123.5 Million USD | 1329.028% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -46078.461% |
| Royalty Pharma plc | 1.79 Billion USD | 15.386% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 2265.624% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 42023521.927% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -655883.163% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 1462.384% |
| Humacyte, Inc. | -76.55 Million USD | 2082.869% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 160016.517% |
| 89bio, Inc. | -273 Thousand USD | 556102.198% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 120854.654% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 179095.991% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1234153.659% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -135546.649% |
| Notable Labs, Ltd. | 113 Thousand USD | -1343161.947% |
| Liquidia Corporation | 14.6 Million USD | -10296.479% |
| Mustang Bio, Inc. | -2.22 Million USD | 68319.596% |
| Immunovant, Inc. | -231 Thousand USD | 657193.506% |
| Quantum-Si incorporated | 488 Thousand USD | -310942.213% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 2832.025% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 5059720.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -81419.119% |
| Acasti Pharma Inc. | -11 Thousand USD | 13799063.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 741918.129% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 234177.668% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1006.136% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -133683.955% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 398495.276% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 77622.268% |
| PepGen Inc. | -1.18 Million USD | 128299.831% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1195285.827% |
| United Therapeutics Corporation | 2.07 Billion USD | 26.672% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 6729.192% |
| Solid Biosciences Inc. | -76.56 Million USD | 2082.532% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 1838112.666% |
| Immuneering Corporation | -764.13 Thousand USD | 198740.298% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -2290564.614% |
| Belite Bio, Inc | -399 Thousand USD | 380522.556% |
| XOMA Corporation | 3.86 Million USD | -39213.287% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 7675.794% |
| Bionomics Limited | -434.44 Thousand USD | 349481.861% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 141430.168% |
| uniQure N.V. | 2.21 Million USD | -68427.585% |
| Cassava Sciences, Inc. | -89.42 Million USD | 1797.422% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 1748.64% |
| Forte Biosciences, Inc. | -9000.00 USD | 16865500.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 181882.754% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 347442.334% |
| Altimmune, Inc. | -65.37 Million USD | 2421.885% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -319.271% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 141430.168% |
| Compugen Ltd. | 31.45 Million USD | -4725.579% |
| Peak Bio, Inc. | 367.76 Thousand USD | -412628.098% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -6091.41% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1405350.0% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 1946107.692% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 126275.062% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 83408.782% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1275634.454% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 126275.062% |
| Instil Bio, Inc. | -4.75 Million USD | 32015.181% |
| argenx SE | 1.1 Billion USD | -36.934% |
| Immunome, Inc. | -8.9 Million USD | 17141.495% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 80411.429% |
| Verona Pharma plc | -679.62 Thousand USD | 223442.024% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 867463.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 63743.019% |
| CervoMed Inc. | -1.29 Million USD | 117435.677% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 63161.321% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 31874.88% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -61328.005% |
| Moolec Science SA | -143.3 Thousand USD | 1059299.609% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 372103.529% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 56917.147% |
| AnaptysBio, Inc. | 14.78 Million USD | -10169.17% |
| Design Therapeutics, Inc. | -537 Thousand USD | 282760.335% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 355576.815% |
| NeurAxis, Inc. | 2.15 Million USD | -70279.895% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -70630.941% |
| Lumos Pharma, Inc. | 2 Million USD | -75529.596% |
| Achilles Therapeutics plc | -4.73 Million USD | 32182.019% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 867463.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 1436471.895% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -4694.522% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -175967.416% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 147181.977% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 3432.498% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -3529867.442% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 184757.664% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 11535941.313% |
| Palisade Bio, Inc. | 246 Thousand USD | -616926.829% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 4599754.545% |
| Beam Therapeutics Inc. | -59.67 Million USD | 2643.716% |
| Neurogene Inc. | -3.26 Million USD | 46632.373% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -989.379% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 41212.839% |
| Sesen Bio, Inc. | 40 Million USD | -3694.715% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 511172.727% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 37792.378% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 15967.51% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -10680.44% |
| Athira Pharma, Inc. | -969 Thousand USD | 156744.582% |
| Vaccinex, Inc. | -16 Million USD | 9584.416% |
| HCW Biologics Inc. | -574.82 Thousand USD | 264161.0% |
| XOMA Corporation | 3.86 Million USD | -39213.287% |
| Nektar Therapeutics | 53.47 Million USD | -2738.337% |
| Arvinas, Inc. | 71.8 Million USD | -2014.047% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 1918.677% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 2517.978% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 471493.168% |
| Rezolute, Inc. | -36 Thousand USD | 4216450.0% |
| Clene Inc. | 533 Thousand USD | -284681.614% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 118215520.561% |
| BeyondSpring Inc. | 1.75 Million USD | -86586.808% |
| Synlogic, Inc. | -1.92 Million USD | 78992.204% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 4102494.595% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 24071.668% |
| Peak Bio, Inc. | 367.76 Thousand USD | -412628.098% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 8104.461% |
| Krystal Biotech, Inc. | 47.6 Million USD | -3088.501% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -975.821% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -30106.687% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 58723.315% |
| MannKind Corporation | 136.19 Million USD | -1014.527% |
| Ikena Oncology, Inc. | -50.49 Million USD | 3106.191% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1294.936% |
| Gossamer Bio, Inc. | -4.38 Million USD | 34715.416% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 602435.714% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 30357820.0% |
| Legend Biotech Corporation | 140.92 Million USD | -977.057% |
| Mural Oncology plc | -2.56 Million USD | 59230.736% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 275578.403% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 1517986.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -7213.703% |
| REGENXBIO Inc. | 53.02 Million USD | -2762.37% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 28434.876% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 789124.561% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 87737.76% |
| Vaxart, Inc. | -60.76 Million USD | 2598.043% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 577726.151% |
| Cellectis S.A. | 18 Thousand USD | -8432600.0% |
| Longeveron Inc. | 221 Thousand USD | -686726.244% |
| Repare Therapeutics Inc. | -80.07 Million USD | 1995.699% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -38.874% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 117401.855% |
| Revolution Medicines, Inc. | -399.66 Million USD | 479.791% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 4336917.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -3097626.531% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 82.365% |
| Denali Therapeutics Inc. | -93.34 Million USD | 1726.103% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 6059767.053% |
| Veru Inc. | 7.56 Million USD | -19962.126% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1005322.517% |
| Cingulate Inc. | -582.91 Thousand USD | 260494.429% |
| Passage Bio, Inc. | -3.72 Million USD | 40892.421% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 12602939.588% |
| Exicure, Inc. | -1.42 Million USD | 106768.025% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 396414.883% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -56055.605% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 296171.78% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -2128.057% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1014682.205% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 2663.737% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -388106.138% |
| OmniAb, Inc. | 14.66 Million USD | -10248.988% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -7492.087% |
| Lipocine Inc. | -2.85 Million USD | 53343.876% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 82459.523% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 26706.24% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 100869.772% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -1915.357% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 2335309.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -1700.662% |
| Ocugen, Inc. | -33.53 Million USD | 4626.004% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 48103.985% |
| Q32 Bio Inc. | 578 Thousand USD | -262510.035% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 572887.17% |
| Alumis Inc. Common Stock | -1.28 Million USD | 118315.421% |
| Equillium, Inc. | 35.95 Million USD | -4121.275% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 89021.265% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -303065.501% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 36717226.27% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 586156.371% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -358982.78% |
| Dominari Holdings Inc. | 2.03 Million USD | -74342.668% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 827416.579% |
| vTv Therapeutics Inc. | -13.59 Million USD | 11265.031% |
| Bio-Techne Corporation | 773.07 Million USD | -96.344% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -8664.282% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -229.412% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 129944.825% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 6429.8% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -12876.712% |
| Nkarta, Inc. | -5.86 Million USD | 25962.77% |
| BioCardia, Inc. | -7.24 Million USD | 21039.247% |
| Iterum Therapeutics plc | -1.75 Million USD | 86836.343% |